| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Access Montana is a Ronan, MT-based company in the Software and Internet sector.
Para is a platform built for app drivers that provides more control, money, and opportunities. It offers a centralized multi-app experience, critical trip information, and the ability to compare all gig offers in one feed.
Aveanna is the nations largest provider of pediatric home care. We offer compassionate and high-quality pediatric skilled nursing, pediatric therapy, autism services, enteral nutrition, therapy and adult services. Find a location near you.
AODocs lets you securely manage your documents and workflows, ensure compliance, and build business applications in G Suite. With solutions for every department, discover how AODocs can help you and your organization.